Literature DB >> 23403127

Involvement of previous non-participants cannot fully compensate for lower participation in a second round of FIT-screening.

M J Denters1, M Deutekom, P M Bossuyt, A F van Rijn, P Fockens, E Dekker.   

Abstract

INTRODUCTION: The effectiveness of colorectal cancer (CRC) screening programs depends on repeated participation. Little is known on later rounds in programs that use the fecal immunochemical test (FIT), in particular whether previous participants are likely to participate again, and if non-participants persist in declining. We compared overall participation in a second round to that in a first round, and evaluated differences in participation rates based on previous response.
METHODS: Asymptomatic persons aged 50-74 years were invited to a second round of a FIT-based CRC screening pilot. We assessed the participation rate overall and within second round subgroups of previous participants, previous non-participants, and first time invitees. We also assessed whether participation rates were similar for males and females and for age groups.
RESULTS: In the first screening round, 2871 of 5309 invitees returned the FIT (participation rate of 57%). This was higher than in the second in which 3187 of 5925 participated (54%; p = 0.0008). Second round participation rate was 85% (2034/2385) among previous participants, 18% (325/1826) among previous non-participants and 48% (828/1714) among first time invitees (p < .0001). Overall, males and persons aged under 55 were less likely to participate.
CONCLUSIONS: Participation in a second round of FIT-screening was significantly lower than in the first round, largely due to a drop in participation in first round participants, and a relatively low response among first time invitees. This loss of uptake was partially compensated by a willingness to be screened in previous non-participants.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23403127     DOI: 10.1016/j.canep.2013.01.007

Source DB:  PubMed          Journal:  Cancer Epidemiol        ISSN: 1877-7821            Impact factor:   2.984


  8 in total

1.  Veterans' Continued Participation in an Annual Fecal Immunochemical Test Mailing Program for Colorectal Cancer Screening.

Authors:  Jennifer A Schlichting; Michelle A Mengeling; Nader M Makki; Ashish Malhotra; Thorvardur R Halfdanarson; J Stacey Klutts; Barcey T Levy; Peter J Kaboli; Mary E Charlton
Journal:  J Am Board Fam Med       Date:  2015 Jul-Aug       Impact factor: 2.657

2.  A Systematic Review of Repeat Fecal Occult Blood Tests for Colorectal Cancer Screening.

Authors:  Caitlin C Murphy; Ahana Sen; Bianca Watson; Samir Gupta; Helen Mayo; Amit G Singal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-11-18       Impact factor: 4.254

3.  Factors Affecting Adherence in a Pragmatic Trial of Annual Fecal Immunochemical Testing for Colorectal Cancer.

Authors:  Carrie M Nielson; William M Vollmer; Amanda F Petrik; Erin M Keast; Beverly B Green; Gloria D Coronado
Journal:  J Gen Intern Med       Date:  2019-01-25       Impact factor: 5.128

4.  Predictors of repeat participation in the NHS bowel cancer screening programme.

Authors:  S H Lo; S Halloran; J Snowball; H Seaman; J Wardle; C von Wagner
Journal:  Br J Cancer       Date:  2014-11-27       Impact factor: 7.640

5.  Behavioural and demographic predictors of adherence to three consecutive faecal occult blood test screening opportunities: a population study.

Authors:  Amy Duncan; Deborah Turnbull; Carlene Wilson; Joanne M Osborne; Stephen R Cole; Ingrid Flight; Graeme P Young
Journal:  BMC Public Health       Date:  2014-03-07       Impact factor: 3.295

6.  Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.

Authors:  Manon van der Vlugt; Esmée J Grobbee; Patrick Mm Bossuyt; Evelien Bongers; Wolfert Spijker; Ernst J Kuipers; Iris Lansdorp-Vogelaar; Marie-Louise Essink-Bot; Manon C W Spaander; Evelien Dekker
Journal:  Br J Cancer       Date:  2016-12-06       Impact factor: 7.640

7.  What can We Learn From High-Performing Screening Programs to Increase Bowel Cancer Screening Participation in Australia?

Authors:  Louisa Flander; Evelien Dekker; Berit Andersen; Mette Bach Larsen; Robert J Steele; Nea Malila; Tytti Sarkeala; Manon van der Vlugt; Clasine de Klerk; Bart Knottnerus; Lucinda Bertels; Anke Woudstra; Manon C W Spaander; Mirjam Fransen; Sirpa Heinavaara; Mary Dillon; Driss Ait Ouakrim; Mark Jenkins
Journal:  Cancer Control       Date:  2022 Jan-Dec       Impact factor: 2.339

8.  Resilience of a FIT screening programme against screening fatigue: a modelling study.

Authors:  Marjolein J E Greuter; Johannes Berkhof; Karen Canfell; Jie-Bin Lew; Evelien Dekker; Veerle M H Coupé
Journal:  BMC Public Health       Date:  2016-09-22       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.